Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
GNTX Stock Summary
Top 10 Correlated ETFs
GNTX
In the News
Gentex (GNTX) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Green Flags: 3 ‘Auto' Stocks to Drive Profits to Your Portfolio
Regarding auto stocks, most investors think of car companies such as General Motors (NYSE: GM ) and Tesla (NASDAQ: TSLA ). However, there are plenty of other companies that benefit from automotive manufacturing.
Here's Why Gentex (GNTX) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Gentex (GNTX) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Buckle Up! 3 Consumer Stock Champions Set for Soaring Growth in 2024.
By their very nature, consumer stocks are the bane of risk-averse investors. High inflationary environments and tight budgets can heavily impact consumer discretionary companies, leading to performance slumps and higher downside risks.
Gentex Corporation (GNTX) Hit a 52 Week High, Can the Run Continue?
Gentex (GNTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Standout Stocks to Buy After Earnings
Booz Allen Hamilton (BAH), Colgate-Palmolive (CL), and Gentex (GNTX) have started to reconfirm their growth expectations after strong quarterly results.
Gentex (GNTX) Q4 Earnings Surpass Estimates, Increase Y/Y
Gentex (GNTX) expects full-year 2024 net sales in the range of $2.45-$2.55 billion.
Gentex (GNTX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Gentex (GNTX) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Gentex (GNTX) Q4 Earnings and Revenues Top Estimates
Gentex (GNTX) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.37 per share a year ago.
GNTX Financial details
GNTX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.38 | 6.96 | 7.35 | 8.31 | 10.02 | |
Net income per share | 1.69 | 1.43 | 1.53 | 1.38 | 1.87 | |
Operating cash flow per share | 2.01 | 1.91 | 1.54 | 1.47 | 2.34 | |
Free cash flow per share | 1.67 | 1.7 | 1.25 | 0.83 | 1.54 | |
Cash per share | 1.73 | 1.86 | 1.14 | 1.03 | 1.05 | |
Book value per share | 7.7 | 8.1 | 8.23 | 8.95 | 10.08 | |
Tangible book value per share | 5.39 | 5.67 | 5.74 | 6.24 | 7.38 | |
Share holders equity per share | 7.7 | 8.1 | 8.23 | 8.95 | 10.08 | |
Interest debt per share | 0 | 0 | 0 | -0.42 | 0 | |
Market cap | 7.3B | 8.23B | 8.21B | 6.29B | 7.49B | |
Enterprise value | 7B | 7.81B | 7.95B | 6.08B | 7.27B | |
P/E ratio | 17.18 | 23.68 | 22.75 | 19.75 | 17.49 | |
Price to sales ratio | 3.93 | 4.88 | 4.74 | 3.28 | 3.26 | |
POCF ratio | 14.42 | 17.72 | 22.66 | 18.61 | 13.95 | |
PFCF ratio | 17.31 | 19.94 | 27.98 | 32.82 | 21.19 | |
P/B Ratio | 3.76 | 4.19 | 4.24 | 3.05 | 3.24 | |
PTB ratio | 3.76 | 4.19 | 4.24 | 3.05 | 3.24 | |
EV to sales | 3.77 | 4.63 | 4.59 | 3.17 | 3.16 | |
Enterprise value over EBITDA | 14.33 | 19.54 | 19.39 | 16.43 | 12.62 | |
EV to operating cash flow | 13.83 | 16.81 | 21.94 | 17.98 | 13.52 | |
EV to free cash flow | 16.61 | 18.92 | 27.09 | 31.7 | 20.55 | |
Earnings yield | 0.06 | 0.04 | 0.04 | 0.05 | 0.06 | |
Free cash flow yield | 0.06 | 0.05 | 0.04 | 0.03 | 0.05 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.61 | -1.06 | -0.64 | -0.58 | -0.39 | |
Current ratio | 5.53 | 5.51 | 4.81 | 3.79 | 3.67 | |
Interest coverage | 0 | 491.36 | 0 | -2.84 | 0 | |
Income quality | 1.19 | 1.34 | 1 | 1.06 | 1.25 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Payout ratio | 0.27 | 0.34 | 0.32 | 0.35 | 0.26 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | |
Intangibles to total assets | 0.27 | 0.27 | 0.28 | 0.27 | 0.24 | |
Capex to operating cash flow | -0.17 | -0.11 | -0.19 | -0.43 | -0.34 | |
Capex to revenue | -0.05 | -0.03 | -0.04 | -0.08 | -0.08 | |
Capex to depreciation | -0.81 | -0.49 | -0.69 | -1.52 | -1.97 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham number | 17.09 | 16.15 | 16.84 | 16.68 | 20.58 | |
ROIC | 0.17 | 0.13 | 0.14 | 0.11 | 0.18 | |
Return on tangible assets | 0.27 | 0.22 | 0.23 | 0.19 | 0.22 | |
Graham Net | 2.01 | 2.24 | 1.78 | 1.67 | 1.68 | |
Working capital | 778.53M | 801.59M | 691.32M | 698.1M | 726.13M | |
Tangible asset value | 1.36B | 1.38B | 1.35B | 1.44B | 1.69B | |
Net current asset value | 719.66M | 745.33M | 679.57M | 687.22M | 698.82M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 224.47M | 260.17M | 267.36M | 263.14M | 299.15M | |
Average payables | 95.18M | 91.17M | 91.56M | 125.04M | 168.07M | |
Average inventory | 237.11M | 237.62M | 271.28M | 360.31M | 403.42M | |
Days sales outstanding | 46.22 | 61.6 | 52.67 | 52.59 | 51.09 | |
Days payables outstanding | 30.42 | 28.58 | 32.3 | 42.31 | 43.8 | |
Days of inventory on hand | 77.62 | 76.28 | 103.86 | 112.74 | 95.6 | |
Receivables turnover | 7.9 | 5.93 | 6.93 | 6.94 | 7.14 | |
Payables turnover | 12 | 12.77 | 11.3 | 8.63 | 8.33 | |
Inventory turnover | 4.7 | 4.78 | 3.51 | 3.24 | 3.82 | |
ROE | 0.22 | 0.18 | 0.19 | 0.15 | 0.19 | |
Capex per share | -0.34 | -0.21 | -0.29 | -0.63 | -0.8 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.12 | 2.39 | 2.54 | 2.5 | 2.55 | |
Net income per share | 0.37 | 0.42 | 0.47 | 0.46 | 0.51 | |
Operating cash flow per share | 0.44 | 0.52 | 0.53 | 0.55 | 0.73 | |
Free cash flow per share | 0.27 | 0.34 | 0.32 | 0.41 | 0.46 | |
Cash per share | 1.02 | 1.05 | 1.12 | 1.21 | 1.04 | |
Book value per share | 8.87 | 9.21 | 9.55 | 9.86 | 9.99 | |
Tangible book value per share | 6.18 | 6.5 | 6.83 | 7.15 | 7.31 | |
Share holders equity per share | 8.87 | 9.21 | 9.55 | 9.86 | 9.99 | |
Interest debt per share | -0.11 | -0.01 | 0 | 0.01 | 0.01 | |
Market cap | 6.35B | 6.46B | 6.73B | 7.49B | 7.56B | |
Enterprise value | 6.14B | 6.25B | 6.49B | 7.23B | 7.33B | |
P/E ratio | 18.43 | 16.56 | 15.41 | 17.87 | 16.16 | |
Price to sales ratio | 12.87 | 11.74 | 11.53 | 13 | 12.83 | |
POCF ratio | 62.36 | 53.46 | 55.69 | 59.46 | 44.58 | |
PFCF ratio | 99.41 | 82.77 | 91.7 | 78.97 | 70.45 | |
P/B Ratio | 3.07 | 3.04 | 3.06 | 3.3 | 3.27 | |
PTB ratio | 3.07 | 3.04 | 3.06 | 3.3 | 3.27 | |
EV to sales | 12.43 | 11.35 | 11.13 | 12.55 | 12.45 | |
Enterprise value over EBITDA | 65.2 | 55.2 | 51 | 59.05 | 48.47 | |
EV to operating cash flow | 60.25 | 51.7 | 53.72 | 57.41 | 43.24 | |
EV to free cash flow | 96.05 | 80.04 | 88.46 | 76.26 | 68.34 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -2.28 | -1.88 | -1.87 | -2.1 | -1.5 | |
Current ratio | 3.79 | 3.38 | 3.71 | 3.85 | 3.67 | |
Interest coverage | -2.88 | -32.51 | 0 | 0 | 48.38 | |
Income quality | 1.18 | 1.24 | 1.11 | 1.2 | 1.45 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.33 | 0.29 | 0.26 | 0.27 | 0.24 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 | |
Intangibles to total assets | 0.27 | 0.26 | 0.25 | 0.24 | 0.24 | |
Capex to operating cash flow | -0.37 | -0.35 | -0.39 | -0.25 | -0.37 | |
Capex to revenue | -0.08 | -0.08 | -0.08 | -0.05 | -0.11 | |
Capex to depreciation | -1.63 | -1.78 | -1.91 | -1.4 | -2.79 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham number | 8.59 | 9.36 | 10.1 | 10.05 | 10.66 | |
ROIC | 0.03 | 0.04 | 0.05 | 0.05 | 0.05 | |
Return on tangible assets | 0.05 | 0.05 | 0.06 | 0.05 | 0.06 | |
Graham Net | 1.66 | 1.65 | 1.85 | 1.95 | 1.66 | |
Working capital | 698.1M | 708.01M | 749.24M | 781.05M | 726.13M | |
Tangible asset value | 1.44B | 1.5B | 1.57B | 1.64B | 1.69B | |
Net current asset value | 687.22M | 694.95M | 734.15M | 765.59M | 698.82M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 284.45M | 304.68M | 341.64M | 350.78M | 336.48M | |
Average payables | 161.59M | 83.54B | 167.69B | 169.91B | 85.77B | |
Average inventory | 411.32M | 403.07M | 395.9M | 392.74M | 398.96M | |
Days sales outstanding | 50.41 | 54.39 | 54.05 | 54.88 | 49.16 | |
Days payables outstanding | 40.19 | 39.95K | 38.84K | 40.12K | 43.02 | |
Days of inventory on hand | 107.1 | 96.16 | 89.92 | 92.59 | 93.9 | |
Receivables turnover | 1.79 | 1.65 | 1.67 | 1.64 | 1.83 | |
Payables turnover | 2.24 | 0 | 0 | 0 | 2.09 | |
Inventory turnover | 0.84 | 0.94 | 1 | 0.97 | 0.96 | |
ROE | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex per share | -0.16 | -0.19 | -0.21 | -0.14 | -0.27 |
GNTX Frequently Asked Questions
What is Gentex Corporation stock symbol ?
Gentex Corporation is a US stock , located in Zeeland of Mi and trading under the symbol GNTX
Is Gentex Corporation buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $26. The lowest prediction is $26 and the highest is $26
What is GNTX stock prediction ?
What is Gentex Corporation stock quote today ?
Gentex Corporation stock price is $36.12 today.
Is Gentex Corporation stock public?
Yes, Gentex Corporation is a publicly traded company.